OpenURL Connection Search

Select item for more details and to access through your institution.

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01075-x
By:
- D'Agostino, Mattia;
- Rota-Scalabrini, Delia;
- Belotti, Angelo;
- Bertamini, Luca;
- Arigoni, Maddalena;
- De Sabbata, Giovanni;
- Pietrantuono, Giuseppe;
- Pascarella, Anna;
- Tosi, Patrizia;
- Pisani, Francesco;
- Pescosta, Norbert;
- Ruggeri, Marina;
- Rogers, Jennifer;
- Olivero, Martina;
- Garzia, Mariagrazia;
- Galieni, Piero;
- Annibali, Ombretta;
- Monaco, Federico;
- Liberati, Anna Marina;
- Palmieri, Salvatore
Publication type:
Article
Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report.
Published in:
American Journal of Hematology, 2024, v. 99, n. 1, p. E29, doi. 10.1002/ajh.27159
By:
- Zaja, Francesco;
- Lucchini, Elisa;
- Poiani, Monica;
- Sbisà, Eugenio;
- Mohamed, Sara;
- De Bellis, Eleonora;
- Caizzi, Manuela;
- Palmieri, Clara;
- Loiacono, Stefano;
- Granzotto, Marilena;
- Sirianni, Francesca;
- De Sabbata, Giovanni
Publication type:
Article
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Published in:
Annals of Hematology, 2024, v. 103, n. 1, p. 125, doi. 10.1007/s00277-023-05443-8
By:
- Barilà, Gregorio;
- Quaglia, Francesca Maria;
- Furlan, Anna;
- Pescosta, Norbert;
- Bonalumi, Angela;
- Marcon, Chiara;
- Pascarella, Anna;
- Tinelli, Martina;
- De March, Elena;
- Lico, Albana;
- Sartori, Roberto;
- Clissa, Cristina;
- De Sabbata, Giovanni;
- Nappi, Davide;
- Porrazzo, Marika;
- De Marchi, Roberta;
- Pavan, Laura;
- Tosetto, Alberto;
- Gherlinzoni, Filippo;
- Krampera, Mauro
Publication type:
Article
A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Published in:
Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7071
By:
- Furlan, Anna;
- Cea, Michele;
- Pavan, Laura;
- Galli, Monica;
- Clissa, Cristina;
- Mangiacavalli, Silvia;
- Cafro, Anna Maria;
- Girlanda, Stefania;
- Patriarca, Francesca;
- Minotto, Claudia;
- Bertoldero, Giovanni;
- Barilà, Gregorio;
- Pascarella, Anna;
- Lico, Albana;
- Paolini, Rossella;
- Rabassi, Nicholas;
- Pescosta, Norbert;
- Porrazzo, Marika;
- De Sabbata, Giovanni;
- Pompa, Alessandra
Publication type:
Article
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1133348
By:
- Mohamed, Sara;
- Lucchini, Elisa;
- Sirianni, Francesca;
- Porrazzo, Marika;
- Ballotta, Laura;
- Ballerini, Mario;
- De Sabbata, Giovanni Maria;
- De Bellis, Eleonora;
- Cappuccio, Ilaria;
- Granzotto, Marilena;
- Toffoletto, Barbara;
- Fortunati, Ilaria;
- Russignan, Anna;
- Florea, Emilia Elzbieta;
- Torelli, Lucio;
- Zaja, Francesco
Publication type:
Article
Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.945060
By:
- Ballotta, Laura;
- Simonetti, Omar;
- D'Agaro, Pierlanfranco;
- Segat, Ludovica;
- Koncan, Raffaella;
- Martinez-Orellana, Pamela;
- Dattola, Federica;
- Orsini, Emanuele;
- Marcello, Alessandro;
- Dal Monego, Simeone;
- Licastro, Danilo;
- Misin, Andrea;
- Mohamed, Sara;
- Sbisà, Eugenio;
- Lucchini, Elisa;
- De Sabbata, Giovanni Maria;
- Zaja, Francesco;
- Luzzati, Roberto
Publication type:
Article

Found: 6

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells.

Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report.

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.

A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".

Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.